Pinealon
Also known as Glu-Asp-Arg, EDR
A short synthetic tripeptide from the bioregulator peptide tradition, studied mainly in neuroprotection, brain aging, and stress-response research models.
Overview
Pinealon is a synthetic tripeptide usually represented as Glu-Asp-Arg or EDR. It is discussed in the bioregulator peptide category and is most often associated with brain-aging and neuroprotection claims.
The Science
As a very short peptide, Pinealon is typically framed around cell-signaling and gene-expression hypotheses rather than classic receptor-drug pharmacology.
- Neuroprotection models - oxidative stress, hypoxia, and neuronal resilience are common themes.
- Brain-aging research - interest centers on cellular stress and repair pathways.
- Bioregulator framing - evidence often comes from regional literature and preclinical systems.
Evidence Snapshot
Pinealon has limited high-quality human evidence. It should be treated as a research peptide with a hypothesis-driven literature, not as a proven cognitive intervention.
Related
More in Cognitive
Adamax
Research compoundCognitive
A Semax-derived cognitive research peptide marketed in nootropic communities, with claims centered on neurotrophic signaling, focus, mood, and stress resilience.
Cerebrolysin
InvestigationalCognitive
A parenteral preparation of small peptides and amino acids derived from porcine brain protein, used clinically for decades across stroke, dementia, and traumatic brain injury recovery in many countries outside the US.
Dermorphin
Research compoundCognitive
A potent opioid heptapeptide originally isolated from frog skin secretions and studied as a tool compound for mu-opioid receptor pharmacology and analgesia research.